Gilead Sciences
GILD
#95
Rank
NZ$309.17 B
Marketcap
NZ$249.20
Share price
4.02%
Change (1 day)
30.41%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$10.86. In 2024 the company made an earnings per share (EPS) of NZ$0.63 a decrease over its 2023 EPS that were of NZ$7.58.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231672.84%
2024NZ$0.63-91.65%
2023NZ$7.5823.98%
2022NZ$6.12-25.86%
2021NZ$8.254850%
2020NZ$0.17-97.64%
2019NZ$7.070.9%
2018NZ$7.0018.71%
2017NZ$5.90-64.88%
2016NZ$16.80-18.45%
2015NZ$20.6055.28%
2014NZ$13.26296.02%
2013NZ$3.3517.89%
2012NZ$2.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.56 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.27-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.99-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.36 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$23.88 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.31 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.45-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$23.88 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.18 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA